Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class ASSE: 600671

Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024

· Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A via Shanghai Stock Exchange
Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis